1. Home
  2. ELVN vs FBRT Comparison

ELVN vs FBRT Comparison

Compare ELVN & FBRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELVN
  • FBRT
  • Stock Information
  • Founded
  • ELVN 2016
  • FBRT 2012
  • Country
  • ELVN United States
  • FBRT United States
  • Employees
  • ELVN N/A
  • FBRT N/A
  • Industry
  • ELVN Biotechnology: Pharmaceutical Preparations
  • FBRT Real Estate Investment Trusts
  • Sector
  • ELVN Health Care
  • FBRT Real Estate
  • Exchange
  • ELVN Nasdaq
  • FBRT Nasdaq
  • Market Cap
  • ELVN 1.2B
  • FBRT 933.1M
  • IPO Year
  • ELVN 2020
  • FBRT 1985
  • Fundamental
  • Price
  • ELVN $22.92
  • FBRT $10.95
  • Analyst Decision
  • ELVN Strong Buy
  • FBRT Strong Buy
  • Analyst Count
  • ELVN 5
  • FBRT 6
  • Target Price
  • ELVN $41.20
  • FBRT $15.25
  • AVG Volume (30 Days)
  • ELVN 728.3K
  • FBRT 744.5K
  • Earning Date
  • ELVN 08-12-2025
  • FBRT 07-30-2025
  • Dividend Yield
  • ELVN N/A
  • FBRT 12.94%
  • EPS Growth
  • ELVN N/A
  • FBRT N/A
  • EPS
  • ELVN N/A
  • FBRT 0.67
  • Revenue
  • ELVN N/A
  • FBRT $175,693,000.00
  • Revenue This Year
  • ELVN N/A
  • FBRT $29.44
  • Revenue Next Year
  • ELVN N/A
  • FBRT $2.22
  • P/E Ratio
  • ELVN N/A
  • FBRT $16.38
  • Revenue Growth
  • ELVN N/A
  • FBRT N/A
  • 52 Week Low
  • ELVN $13.30
  • FBRT $10.50
  • 52 Week High
  • ELVN $30.03
  • FBRT $14.12
  • Technical
  • Relative Strength Index (RSI)
  • ELVN 60.45
  • FBRT 49.52
  • Support Level
  • ELVN $19.38
  • FBRT $10.69
  • Resistance Level
  • ELVN $21.34
  • FBRT $11.06
  • Average True Range (ATR)
  • ELVN 1.27
  • FBRT 0.18
  • MACD
  • ELVN 0.11
  • FBRT 0.03
  • Stochastic Oscillator
  • ELVN 88.47
  • FBRT 68.14

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.

About FBRT Franklin BSP Realty Trust Inc.

Franklin BSP Realty Trust Inc is a private real estate investment trust that originates, acquires, and manages a diversified portfolio of commercial real estate debt, and first mortgage loans. secured by properties located in the United States. Its segments include the real estate debt business; the real estate securities business; the real estate owned business; and the commercial real estate conduit business.

Share on Social Networks: